APLN and cancer: The result revealed that the ASD-2 subtype in BLCA demonstrated an increase in the MicroRNAs in Cancer and Apelin signaling pathways (Fig. 4a), which have a tumor-promoting effect via the PI3k/Akt pathway or the activation of Notch3 and STAT3 (29).